BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 25072271)

  • 21. Dual-hormone treatment with insulin and glucagon in patients with type 1 diabetes.
    Reiband HK; Schmidt S; Ranjan A; Holst JJ; Madsbad S; Nørgaard K
    Diabetes Metab Res Rev; 2015 Oct; 31(7):672-9. PubMed ID: 25533565
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Progress of artificial pancreas devices towards clinical use: the first outpatient studies.
    Russell SJ
    Curr Opin Endocrinol Diabetes Obes; 2015 Apr; 22(2):106-11. PubMed ID: 25692927
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Artificial pancreas: fuzzy logic and control of glycemia.
    Nimri R; Phillip M
    Curr Opin Endocrinol Diabetes Obes; 2014 Aug; 21(4):251-6. PubMed ID: 24937038
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypoglycemia in type 1 diabetes: a still unresolved problem in the era of insulin analogs and pump therapy.
    Shalitin S; Phillip M
    Diabetes Care; 2008 Feb; 31 Suppl 2():S121-4. PubMed ID: 18227471
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safe glycemic management during closed-loop treatment of type 1 diabetes: the role of glucagon, use of multiple sensors, and compensation for stress hyperglycemia.
    Ward WK; Castle JR; El Youssef J
    J Diabetes Sci Technol; 2011 Nov; 5(6):1373-80. PubMed ID: 22226254
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intensive insulin therapy in patients with type 1 diabetes mellitus.
    Switzer SM; Moser EG; Rockler BE; Garg SK
    Endocrinol Metab Clin North Am; 2012 Mar; 41(1):89-104. PubMed ID: 22575408
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [From insulin pump and continuous glucose monitoring to the artificial pancreas].
    Apablaza P; Soto N; Codner E
    Rev Med Chil; 2017 May; 145(5):630-640. PubMed ID: 28898340
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Emerging diabetes therapies and technologies.
    Moser EG; Morris AA; Garg SK
    Diabetes Res Clin Pract; 2012 Jul; 97(1):16-26. PubMed ID: 22381908
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Perioperative intensive insulin therapy using an artificial endocrine pancreas with closed-loop glycemic control system: the effects of no hypoglycemia.
    Hanazaki K; Kitagawa H; Yatabe T; Munekage M; Dabanaka K; Takezaki Y; Tsukamoto Y; Asano T; Kinoshita Y; Namikawa T
    Am J Surg; 2014 Jun; 207(6):935-41. PubMed ID: 24480234
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A cost-effectiveness analysis of sensor-augmented insulin pump therapy and automated insulin suspension versus standard pump therapy for hypoglycemic unaware patients with type 1 diabetes.
    Ly TT; Brnabic AJ; Eggleston A; Kolivos A; McBride ME; Schrover R; Jones TW
    Value Health; 2014 Jul; 17(5):561-9. PubMed ID: 25128049
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insulin delivery and nocturnal glucose control in children and adolescents with type 1 diabetes.
    Tauschmann M; Hovorka R
    Expert Opin Drug Deliv; 2017 Dec; 14(12):1367-1377. PubMed ID: 28819992
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Continuous Glucose Monitoring, Future Products, and Update on Worldwide Artificial Pancreas Projects.
    Kropff J; DeVries JH
    Diabetes Technol Ther; 2016 Feb; 18 Suppl 2(Suppl 2):S253-63. PubMed ID: 26784131
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nocturnal hypoglycemia in patients with insulin-treated diabetes.
    Yale JF
    Diabetes Res Clin Pract; 2004 Sep; 65 Suppl 1():S41-6. PubMed ID: 15315870
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison between a novel and conventional artificial pancreas for perioperative glycemic control using a closed-loop system.
    Namikawa T; Munekage M; Kitagawa H; Yatabe T; Maeda H; Tsukamoto Y; Hirano K; Asano T; Kinoshita Y; Hanazaki K
    J Artif Organs; 2017 Mar; 20(1):84-90. PubMed ID: 27651347
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Managing Patients with Insulin Pumps and Continuous Glucose Monitors in the Hospital: to Wear or Not to Wear.
    Yeh T; Yeung M; Mendelsohn Curanaj FA
    Curr Diab Rep; 2021 Jan; 21(2):7. PubMed ID: 33449214
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Technology to Reduce Hypoglycemia.
    Yeoh E; Choudhary P
    J Diabetes Sci Technol; 2015 Jul; 9(4):911-6. PubMed ID: 25883167
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Efficacy of Technology in Type 1 Diabetes: A Systematic Review, Network Meta-analysis, and Narrative Synthesis.
    Pease A; Lo C; Earnest A; Kiriakova V; Liew D; Zoungas S
    Diabetes Technol Ther; 2020 May; 22(5):411-421. PubMed ID: 31904262
    [No Abstract]   [Full Text] [Related]  

  • 38. An artificial pancreas for automated blood glucose control in patients with Type 1 diabetes.
    Schmidt S; Boiroux D; Ranjan A; Jørgensen JB; Madsen H; Nørgaard K
    Ther Deliv; 2015; 6(5):609-19. PubMed ID: 26001176
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypoglycemia in insulin-treated diabetes: a case for increased vigilance.
    Unger J; Parkin C
    Postgrad Med; 2011 Jul; 123(4):81-91. PubMed ID: 21680992
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Towards an artificial pancreas at home.
    Renard E; Farret A; Place J; Wojtusciszyn A; Bringer J
    Diabetes Metab; 2011 Dec; 37 Suppl 4():S94-8. PubMed ID: 22208718
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.